Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.

By End Use;

Hospitals, Clinics, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn105987076 Published Date: April, 2025 Updated Date: May, 2025

Introduction

Global Intracranial Aneurysm Market (USD Million), 2021 - 2031

In the year 2024, the Global Intracranial Aneurysm Market was valued at USD 1,153.25 million. The size of this market is expected to increase to USD 2,549.47 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%


Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 12.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)12.0 %
Market Size (2024)USD 1,153.25 Million
Market Size (2031)USD 2,549.47 Million
Market ConcentrationLow
Report Pages364
1,153.25
2024
2,549.47
2031

Major Players

  • Stryker Corporation
  • MicroPort Scientific Corporation.
  • Johnson & Johnson Services, Inc.
  • MicroVention Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences
  • RAUMEDIC AG
  • Terumo Corporation
  • Delta Surgical

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Intracranial Aneurysm Market

Fragmented - Highly competitive market without dominant players


Market Overview
The intracranial aneurysm market is witnessing notable expansion, with projections indicating a rise from USD 1,029.69 million in 2023 to approximately USD 2,276.31 million by 2030. This reflects a steady compound annual growth rate (CAGR) of 12%, driven by the rising need for effective aneurysm treatment solutions and innovations in neurovascular care. Key Growth Drivers
The market’s momentum is fueled by several critical factors. The increasing prevalence of intracranial aneurysms—linked to aging populations and lifestyle risks such as smoking and high blood pressure—is a major contributor. Enhanced patient awareness and a greater focus on early diagnosis are also accelerating treatment demand. Moreover, medical technology improvements are delivering more precise and efficient options for both detection and intervention. Technological Innovations
Rapid advancements in medical technology are reshaping how intracranial aneurysms are diagnosed and treated. Enhanced imaging tools allow for earlier and more accurate detection, while AI-powered diagnostics support timely clinical decisions. In addition, the growing adoption of minimally invasive procedures is reducing recovery times and enhancing procedural success rates. Competitive Landscape
The intracranial aneurysm market is fairly consolidated, with key players leading through robust R&D investment. These companies are consistently introducing next-generation devices and therapies that aim to improve patient outcomes while minimizing procedural risks. Their focus on innovation and precision medicine is helping to set new benchmarks in the field of neurovascular health.
  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By End Use
    3. Market Snapshot, By Region
  4. Global Intracranial Aneurysm Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rise in minimally invasive procedures demand
        2. Growing elderly population with neurological risks
        3. Increased use of advanced imaging techniques
        4. Rising awareness of aneurysm treatment options
  5. Restraints
    1. High cost of aneurysm treatments
    2. Risks linked to invasive surgeries
    3. Limited diagnosis in emerging regions
    4. Slow regulatory approval for innovations
  6. Opportunities
    1. Growth in healthcare infrastructure worldwide
    2. Technological advancements in coiling devices
    3. Expanding telemedicine for early diagnosis
    4. Rising R&D in neurovascular therapies
  7. PEST Analysis
    1. Political Analysis
    2. Economic Analysis
    3. Social Analysis
    4. Technological Analysis
  8. Porter's Analysis
    1. Bargaining Power of Suppliers
    2. Bargaining Power of Buyers
    3. Threat of Substitutes
    4. Threat of New Entrants
    5. Competitive Rivalry
  9. Market Segmentation
    1. Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
      1. Surgical Clipping

      2. Endovascular Coiling

      3. Flow Diverters

      4. Others

    2. Global Intracranial Aneurysm Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals

      2. Clinics

      3. Others

    3. Global Intracranial Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  10. Competitive Landscape
    1. Company Profiles
      1. Stryker Corporation
      2. MicroPort Scientific Corporation.
      3. Johnson & Johnson Services, Inc.
      4. MicroVention Inc.
      5. B. Braun Melsungen AG
      6. Integra LifeSciences
      7. RAUMEDIC AG
      8. Terumo Corporation
      9. Delta Surgical
  11. Analyst Views
  12. Future Outlook of the Market